BioServe Biotechnologies

Hyderabad, India Founded: 2002 • Age: 24 yrs Acquired By ReproCELL
DNA synthesis, sequencing, extraction, and biomarker discovery services are provided.
Request Access

About BioServe Biotechnologies

BioServe Biotechnologies is a company based in Hyderabad (India) founded in 2002 was acquired by ReproCELL in April 2018.. The company has 28 employees as of April 06, 2024. BioServe Biotechnologies operates in a competitive market with competitors including Omniome, Biofidelity, Novogene Corporation, HitGen and Singular Genomics, among others.

  • Headquarter Hyderabad, India
  • Employees 28 as on 06 Apr, 2024
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Bioserve Biotechnologies (India) Private Limited
  • Date of Incorporation 21 Feb, 1994
  • Jurisdiction Uppal, Telangana, India
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
    $757.11 K (USD)
    26.62
    as on Mar 31, 2023
  • Net Profit
    $-290.7 K (USD)
    34.77
    as on Mar 31, 2023
  • EBITDA
    $-154.45 K (USD)
    47.79
    as on Mar 31, 2023
  • Latest Funding Round
  • Investors
  • Employee Count
    28

    as on Apr 06, 2024

  • Acquired by
    ReproCELL

    & 1 more

    (Apr 27, 2018)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of BioServe Biotechnologies

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in BioServe Biotechnologies

BioServe Biotechnologies has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Cancer Genetics and ReproCELL. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Leading global supplier of iPS-derived cells, stem cell reagents, human biofluids, and 3D cell culture.
Founded Year Domain Location
Cancer diagnostic solutions are developed for personalized genetic treatments.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by BioServe Biotechnologies

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - BioServe Biotechnologies

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Bioserve Biotechnologies Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of BioServe Biotechnologies

BioServe Biotechnologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Biofidelity, Novogene Corporation, HitGen and Singular Genomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Genome sequencing platform is provided for clinical diagnostics.
domain founded_year HQ Location
Molecular diagnostic assays are developed for target DNA sequence detection.
domain founded_year HQ Location
Genomic services and solutions with NGS expertise are provided.
domain founded_year HQ Location
DNA-encoded libraries are developed for drug discovery applications.
domain founded_year HQ Location
Next-generation gene sequencing and multi-omics technologies are provided.
domain founded_year HQ Location
Enzymatic DNA synthesis products are provided for researchers.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Bioserve Biotechnologies

Frequently Asked Questions about BioServe Biotechnologies

When was BioServe Biotechnologies founded?

BioServe Biotechnologies was founded in 2002.

Where is BioServe Biotechnologies located?

BioServe Biotechnologies is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

How many employees does BioServe Biotechnologies have?

As of Apr 06, 2024, the latest employee count at BioServe Biotechnologies is 28.

What is the annual revenue of BioServe Biotechnologies?

Annual revenue of BioServe Biotechnologies is $757.11K as on Mar 31, 2023.

What does BioServe Biotechnologies do?

BioServe Biotechnologies was founded in 2002 in Hyderabad, India, within the biotechnology sector. DNA synthesis, sequencing, extraction, and biomarker discovery services are offered to support research and diagnostics. Therapeutics targeting Rett syndrome, Parkinsons disease, glioblastoma, CDKL5 deficiency disorder, and related conditions are developed. Additional services include food pathogen testing and detection of genetically modified organisms in finished products. Molecular biology kits for research purposes are manufactured and supplied.

Who are the top competitors of BioServe Biotechnologies?

BioServe Biotechnologies's top competitors include Novogene Corporation, Singular Genomics and Omniome.

Who are BioServe Biotechnologies's investors?

BioServe Biotechnologies has 2 investors. Key investors include Cancer Genetics, and ReproCELL.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available